Related posts: Verily and Lumea Announce Development Partnership Three digital pathology leaders converge to streamline processes, enhance diagnostics, and improve patient outcomes Lumea recognized as Best of State Winner for…
Welcome to PathPulse: Pathology Innovators in Action. Today, we’re honored to host Dr. Liron Pantanowitz, the Maud L. Menten Professor and Chair of the Department of Pathology at UPMC and…
Lumea is thrilled to announce our participation in the Solaris Health 2025 Physician Conference on January 17–18, 2025, at the iconic InterContinental Miami. This event offers a great opportunity for…
Lumea is proud to announce our attendance at the inaugural International Congress on Frontiers in Urologic Oncology and Uropathology on January 10-12, 2025, in Bhubaneswar, Odisha, India. This event brings together…
As digital pathology continues to revolutionize the field of diagnostics and research, staying informed about the latest developments is more crucial than ever. Attending industry-leading conferences is an excellent way…
How Goldfinch Laboratory Scaled a Start-Up Lab with a Dream, a Shoestring Budget, and Digital Pathology Goldfinch Laboratory was created in 2023 by a small pathologist group with a dream:…
LEHI, UT, UNITED STATES, December 5, 2024 /EINPresswire.com/ — Lumea, a leader in digital pathology solutions, is excited to announce that Cxbladder™, a suite of non-invasive genomic urine tests optimized…
In this episode of PathPulse: Pathology Innovators in Action, we were thrilled to welcome neuropathologist Margaret Flanagan, MD, to talk with us about what is missing from digital pathology, highlighting…
Lumea is thrilled to announce our participation in the 11th Digital Pathology & AI Congress: Europe, taking place December 11-12, 2024, in London, UK. This premier event is an unparalleled…
Are you looking for a whole slide image (WSI) scanner? Whether this is your first time buying one or you’re a seasoned digital pathology expert looking to expand your existing…
*BxLink has not been approved by the FDA for digital primary diagnosis. Refer to CAP guidelines regarding the use of digital pathology technologies.
